Serpil Erol

1.7k total citations
54 papers, 1.2k citations indexed

About

Serpil Erol is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Serpil Erol has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Infectious Diseases and 13 papers in Hepatology. Recurrent topics in Serpil Erol's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis Viruses Studies and Epidemiology (7 papers). Serpil Erol is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis Viruses Studies and Epidemiology (7 papers). Serpil Erol collaborates with scholars based in Türkiye, United Kingdom and India. Serpil Erol's co-authors include Ülkü Altoparlak, Müfide Nuran Akçay, Fehmi Çelebi, Zülal Özkurt, Ayten Kadanalı, Mehmet A. Taşyaran, Mehmet Parlak, Mustafa Ertek, Mehmet Parlak and Mehmet Ali Gündoğdu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Microbiology and Infection and Infection Control and Hospital Epidemiology.

In The Last Decade

Serpil Erol

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serpil Erol Türkiye 13 402 346 258 223 156 54 1.2k
Necla Tülek Türkiye 22 466 1.2× 330 1.0× 125 0.5× 61 0.3× 178 1.1× 90 1.2k
Timothy J. Whitman United States 18 244 0.6× 259 0.7× 157 0.6× 41 0.2× 179 1.1× 49 892
John P. Leeming United Kingdom 30 961 2.4× 422 1.2× 125 0.5× 42 0.2× 253 1.6× 54 2.1k
Vedat Turhan Türkiye 17 243 0.6× 184 0.5× 142 0.6× 288 1.3× 242 1.6× 71 948
Paul Chadwick United Kingdom 20 413 1.0× 473 1.4× 234 0.9× 64 0.3× 111 0.7× 98 1.6k
Kei Yamamoto Japan 16 262 0.7× 467 1.3× 279 1.1× 134 0.6× 450 2.9× 119 1.2k
Heather C. Yun United States 20 320 0.8× 307 0.9× 203 0.8× 86 0.4× 245 1.6× 78 1.2k
David M. Bamberger United States 19 529 1.3× 768 2.2× 270 1.0× 73 0.3× 174 1.1× 45 1.5k
Gholamreza Pouladfar Iran 18 371 0.9× 206 0.6× 119 0.5× 47 0.2× 269 1.7× 87 973
Christina Forstner Austria 19 471 1.2× 495 1.4× 99 0.4× 28 0.1× 108 0.7× 55 937

Countries citing papers authored by Serpil Erol

Since Specialization
Citations

This map shows the geographic impact of Serpil Erol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serpil Erol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serpil Erol more than expected).

Fields of papers citing papers by Serpil Erol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serpil Erol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serpil Erol. The network helps show where Serpil Erol may publish in the future.

Co-authorship network of co-authors of Serpil Erol

This figure shows the co-authorship network connecting the top 25 collaborators of Serpil Erol. A scholar is included among the top collaborators of Serpil Erol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serpil Erol. Serpil Erol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Parlak, Emine, Ferhan Kerget, Tuna Demırdal, et al.. (2021). The Epidemiology, Clinical Manifestations, Radiology, Microbiology, Treatment, and Prognosis of Echinococcosis: Results of NENEHATUN Study. Vector-Borne and Zoonotic Diseases. 21(12). 948–954. 2 indexed citations
3.
Alay, Handan, et al.. (2018). Assessment of Quality of Life of Patients with Chronic Hepatitis B and C Treated with Pegylated Interferon-alpha. SHILAP Revista de lepidopterología. 24(2). 25–42. 3 indexed citations
4.
Erol, Serpil, et al.. (2011). Evaluation of the tick bites in a Crimean-Congo haemorrhagic fever (CCHF) endemic area in Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES. 4 indexed citations
5.
Erol, Serpil, Leyla Sağlam, Ahmet Özbek, & Ayten Kadanalı. (2009). HEPATITIS C VIRUS INFECTION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Hepatitis Monthly. 9(122). 39–44. 6 indexed citations
6.
Erol, Serpil, Zülal Özkurt, Ayten Kadanalı, & Kemalettin Özden. (2009). The Etiological Role of Parameningeal Infections in Adult Patients with Community-Acquired Acute Bacterial Meningitis in Eastern Turkey. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(6). 1483–1490.
7.
Erol, Serpil, Zülal Özkurt, Ahmet Özbek, & Mehmet Parlak. (2009). Poor response to treatment with Peg-IFN containing regimens in patients coinfected with hepatitis B and hepatitis C virus.. Hepatitis Monthly. 9(3). 224–228. 3 indexed citations
8.
Özkurt, Zülal, Mustafa Ertek, Ayten Kadanalı, Serpil Erol, & Mehmet Parlak. (2005). Fatal Liver Failure Secondary to Chemotherapy Induced Hepatitis-B Virus Reactivation in a Patient with Acute Myeloid Leukemia. DergiPark (Istanbul University). 2 indexed citations
9.
Özkurt, Zülal, et al.. (2005). [A transfusion-transmitted malaria case].. PubMed. 39(1). 101–5. 1 indexed citations
10.
Özkurt, Zülal, Ayten Kadanalı, Mustafa Ertek, Serpil Erol, & Mehmet Parlak. (2005). Cerrahi profilakside antibiyotik kullanımı. ANKEM Dergisi. 19(3). 111–114.
11.
Özkurt, Zülal, Mustafa Ertek, Serpil Erol, Ülkü Altoparlak, & Müfide Nuran Akçay. (2005). The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit. Burns. 31(7). 870–873. 50 indexed citations
12.
Özkurt, Zülal, İlhami Kıkı, Serpil Erol, et al.. (2005). Crimean–Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. Journal of Infection. 52(3). 207–215. 153 indexed citations
13.
Erol, Serpil, Ülkü Altoparlak, Müfide Nuran Akçay, Fehmi Çelebi, & Mehmet Parlak. (2004). Changes of microbial flora and wound colonization in burned patients. Burns. 30(4). 357–361. 187 indexed citations
14.
Erol, Mustafa Kemal, Serpil Erol, Mehmet Koruk, Mustafa Ertek, & Engin Bozkurt. (2004). Effects of interferon-? therapy on cardiac function in patients with chronic hepatitis B infection. Heart and Vessels. 19(6). 263–266. 7 indexed citations
15.
Erol, Serpil, et al.. (2003). Erzurum ve çevresinde hepatit B virüs infeksiyonu seroprevalansı. 17(4). 389–393. 2 indexed citations
16.
Hoşoğlu, Salih, Mustafa Sünbül, Serpil Erol, et al.. (2003). A National Survey of Surgical Antibiotic Prophylaxis in Turkey. Infection Control and Hospital Epidemiology. 24(10). 758–761. 46 indexed citations
17.
Erol, Serpil, Zülal Özkurt, Mustafa Ertek, & Mehmet A. Taşyaran. (2003). Intrafamilial transmission of hepatitis B virus in the eastern Anatolian region of Turkey. European Journal of Gastroenterology & Hepatology. 15(4). 345–349. 35 indexed citations
18.
Taşyaran, Mehmet A. & Serpil Erol. (2002). Penicillin Therapy for Anthrax: A Reply to Torres-Tortosa et al.. European Journal of Clinical Microbiology & Infectious Diseases. 21(9). 697–697. 1 indexed citations
19.
Özkurt, Zülal, Serpil Erol, Mehmet A. Taşyaran, & Avni Kaya. (2002). Detection of Brucella melitensis by the BacT/Alert automated system and Brucella broth culture. Clinical Microbiology and Infection. 8(11). 749–752. 12 indexed citations
20.
Erol, Serpil, et al.. (1985). Is retention required in childrens pulled elbow after the reduction. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Necla Tülek Breakdown of academic impact, for papers by Timothy J. Whitman Breakdown of academic impact, for papers by John P. Leeming Breakdown of academic impact, for papers by Vedat Turhan Breakdown of academic impact, for papers by Paul Chadwick Breakdown of academic impact, for papers by Kei Yamamoto Breakdown of academic impact, for papers by Heather C. Yun Breakdown of academic impact, for papers by David M. Bamberger Breakdown of academic impact, for papers by Gholamreza Pouladfar Breakdown of academic impact, for papers by Christina Forstner
Rankless by CCL
2026